Atlas Trials

Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)

Clinical trial NCT04031898 · COMPLETED

Trial details

NCT number
NCT04031898
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Lung Cancer
Start date
2019-05-07
Primary completion
2019-12-31
Enrollment
896

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.